No company matches — see all tickers
Joe Fitzgerald becomes COO as new Interventional Therapies, Rhythm Solutions and MedSurg segments aim to speed decisions and support growth.
MedSurg and Asia Pacific chief Arthur C. Butcher to retire Jan. 1, 2027, with a planned senior-advisor stint through Feb. 26.
Cybersecurity incident disrupted global networks, manufacturing and order shipments, making Q3 and FY2026 sales growth and adjusted EPS guidance unlikely to be met.
Cybersecurity incident disrupts global operations, limiting access to systems used to process and ship customer orders.
Farapulse and AGENT drive cardiovascular growth; tariff recovery lifts margins while inventory absorbs cash.
MiRus investment secures an exclusive option to acquire its TAVR business; accelerated share repurchase completed.
Global restructuring targets supply-chain efficiencies and job cuts through 2029, with substantial savings expected to be reinvested in growth.
Coverage: 10-K, 10-Q and 8-K filings filed since Jul 1, 2026.
Request longer coverage
Company data: Wikidata Q894585
We read every message.
